Literature DB >> 9353265

Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain.

V J Venema1, H Ju, R Zou, R C Venema.   

Abstract

Neuronal nitric-oxide synthase (nNOS) has been shown previously to interact with alpha1-syntrophin in the dystrophin complex of skeletal muscle. In the present study, we have examined whether nNOS also interacts with caveolin-3 in skeletal muscle. nNOS and caveolin-3 are coimmunoprecipitated from rat skeletal muscle homogenates by antibodies directed against either of the two proteins. Synthetic peptides corresponding to the membrane-proximal caveolin-3 residues 65-84 and 109-130 and homologous caveolin-1 residues 82-101 and 135-156 potently inhibit the catalytic activity of purified, recombinant nNOS. Purified nNOS also binds to a glutathione S-transferase-caveolin-1 fusion protein in in vitro binding assays. In vitro binding is completely abolished by preincubation of nNOS with either of the two caveolin-3 inhibitory peptides. Interactions between nNOS and caveolin-3, therefore, appear to be direct and to involve two distinct caveolin scaffolding/inhibitory domains. Other caveolin-interacting enzymes, including endothelial nitric-oxide synthase and the c-Src tyrosine kinase, are also potently inhibited by each of the four caveolin peptides. Inhibitory interactions mediated by two different caveolin domains may thus be a general feature of enzyme docking to caveolin proteins in plasmalemmal caveolae.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353265     DOI: 10.1074/jbc.272.45.28187

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  There's NO binding like NOS binding: protein-protein interactions in NO/cGMP signaling.

Authors:  Pavel I Nedvetsky; William C Sessa; Harald H H W Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

4.  Diseases caused by mutations in Nav1.5 interacting proteins.

Authors:  John W Kyle; Jonathan C Makielski
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

5.  Immunolocalization of caveolin-1 in rat and human mesothelium.

Authors:  Christopher J von Ruhland; Lee Campbell; Mark Gumbleton; Bharat Jasani; Geoffrey R Newman
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

6.  Exploring the interaction between the protein kinase A catalytic subunit and caveolin-1 scaffolding domain with shotgun scanning, oligomer complementation, NMR, and docking.

Authors:  Aron M Levin; John G Coroneus; Melanie J Cocco; Gregory A Weiss
Journal:  Protein Sci       Date:  2006-02-01       Impact factor: 6.725

Review 7.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

8.  Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport.

Authors:  Chunying Li; Wei Huang; M Brennan Harris; Jonathan M Goolsby; Richard C Venema
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

9.  Essential role of the 90-kilodalton heat shock protein in mediating nongenomic estrogen signaling in coronary artery smooth muscle.

Authors:  Guichun Han; Handong Ma; Rajesh Chintala; David J R Fulton; Scott A Barman; Richard E White
Journal:  J Pharmacol Exp Ther       Date:  2009-03-17       Impact factor: 4.030

Review 10.  Caveolin: a key target for modulating nitric oxide availability in health and disease.

Authors:  Bikramjit Dhillon; Mitesh V Badiwala; Shu-Hong Li; Ren-Ke Li; Richard D Weisel; Donald A G Mickle; Paul W M Fedak; Vivek Rao; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.